Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Rozhl Chir ; 94(7): 301-5, 2015 Jul.
Article in Czech | MEDLINE | ID: mdl-26305351

ABSTRACT

Heterotopic mesenteric ossification (HMO) is a rare disease inducing pathological bone tissue formation in the abdominal cavity after multiple operational traumas. The authors present an unusual case of mesenteric ossification formation in a 30 year-old man after surgery due to status ileosus on the basis of intestinal incarceration. After being released into home treatment the patient had to be hospitalized again and reoperated. During the next six weeks, the patient was reoperated three more times due to intestinal status ileosus and significant leaking of the entero-cutaneous fistula. Despite intensive parenteral hyperalimentation the patients condition did not improve and metabolic breakdown became fatal for the patient. Pathophysiology of the mechanism of bone tissue formation in soft tissues is unknown.


Subject(s)
Mesentery/pathology , Ossification, Heterotopic/complications , Peritoneal Diseases/etiology , Adult , Fatal Outcome , Humans , Male , Postoperative Complications
2.
Ceska Gynekol ; 78(2): 206-10, 2013 Apr.
Article in Czech | MEDLINE | ID: mdl-23710987

ABSTRACT

Lymphangioleiomyomatosis (LAM) is a rare progressive disease affecting women of childbearing age. The disease is characterised by an abnormal proliferation of immature smooth muscle cells predominantly in the lung. It gradually leads to respiratory failure, and it frequently result in death. Extrapulmonary LAM typically presents with abdominal mass, abdominal pain and chylous ascites. In the case reports we describe two cases of premenopausal females with extrapulmonary LAM. In both cases they occur in pelvic location in the obturator fossa and around the external iliac artery. After surgical procedures patients were primary treated with progesterone. Sirolimus was second-line drugs.


Subject(s)
Lymphangioleiomyomatosis , Retroperitoneal Neoplasms , Adult , Antineoplastic Agents/therapeutic use , Female , Humans , Progesterone/therapeutic use , Sirolimus/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...